{"id":"NCT02294058","sponsor":"Celgene","briefTitle":"Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)","officialTitle":"A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-03","primaryCompletion":"2016-12-22","completion":"2016-12-22","firstPosted":"2014-11-19","resultsPosted":"2020-11-25","lastUpdate":"2020-11-25"},"enrollment":1346,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"Ozanimod","otherNames":["RPC1063","Zeposia®"]},{"type":"DRUG","name":"Interferon beta-1a","otherNames":["Avonex®","IFN β-1a"]},{"type":"DRUG","name":"Placebo to ozanimod","otherNames":[]},{"type":"DRUG","name":"Placebo to interferon beta-1a","otherNames":[]}],"arms":[{"label":"Interferon beta-1a","type":"ACTIVE_COMPARATOR"},{"label":"Ozanimod 0.5 mg","type":"EXPERIMENTAL"},{"label":"Ozanimod 1 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).","primaryOutcome":{"measure":"Adjusted Annualized Relapse Rate (ARR) During the Treatment Period","timeFrame":"12 months","effectByArm":[{"arm":"Interferon Beta-1a","deltaMin":0.35,"sd":null},{"arm":"Ozanimod 0.5 mg","deltaMin":0.241,"sd":null},{"arm":"Ozanimod 1 mg","deltaMin":0.181,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0013"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":224,"countries":["United States","Belarus","Bosnia and Herzegovina","Bulgaria","Canada","Croatia","Czechia","Estonia","Georgia","Germany","Hungary","Latvia","Lithuania","Moldova","Netherlands","New Zealand","Poland","Portugal","Romania","Russia","Serbia","Spain","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":["31492651","40462564","33454584"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":445},"commonTop":["Influenza Like Illness","Nasopharyngitis","Headache","Upper Respiratory Tract Infection","Pyrexia"]}}